United States Over the Counter Drugs Market by Formulation Type (Liquids, Tablets, Ointments, Sprays), by Product Type (Analgesics, Antiseptics, Anti-Allergy Drugs, Cough, Cold and Flu Drugs, Dermatologics, Gastrointestinal drugs, Vitamins and Minerals, Weight Loss/Diet Drugs, Sleep Aids, Ophthalmics, Smoking Cession Aids and Other Products), by Distribution Channel (Pharmacies, Supermarkets/Hypermarkets, convenience stores, others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

United States Over the Counter Drugs Market by Formulation Type (Liquids, Tablets, Ointments, Sprays), by Product Type (Analgesics, Antiseptics, Anti-Allergy Drugs, Cough, Cold and Flu Drugs, Dermatologics, Gastrointestinal drugs, Vitamins and Minerals, Weight Loss/Diet Drugs, Sleep Aids, Ophthalmics, Smoking Cession Aids and Other Products), by Distribution Channel (Pharmacies, Supermarkets/Hypermarkets, convenience stores, others) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 805 | Pages: 125 | October 2016 | Region: United States


The United States Over the Counter Drugs Market was worth $23.176 billion in 2016 and estimated to be growing at a CAGR of 6.2%, to reach $31.752 billion by 2021. The market is showcasing evident potential in the mentioned forecasting period. Over the counter (OTC) drugs are the effective and safe drugs, that can be bought without the prescription from pharmacies and local stores. Aspirin, Acetaminophen and ibuprofen are the most common OTC drugs in the United States.

OTC medicines provides 24/7 access to healthcare options for busy families and caregivers. It is estimated that in United States there are a total of 2.9 billion retail trips annually to purchase OTC products. To avail the OTC drugs there are about 54,000 pharmacies, and more than 7,50,000 retail outlets in United States. On average, United States households spend about $338 per year on Over the Counter Drugs.

United States Market for OTC drugs is driven by proactive approach towards ailments. Shift from Rx-to-OTC among people represent the core driver of market growth. Increasing number of mergers and acquisitions are also playing a crucial role in reshaping the United States OTC drugs market. While drug abuse is the major factor hindering the market growth.

United States Over the Counter Drugs market is broadly categorized into Formulation, Product Type and Distribution Channel. On the Basis of formulation, the market is segmented into Liquids, Tablets, Ointments and Sprays. Based on Product Type the market is analysed as Analgesics, Antiseptics, Anti-Allergy Drugs, Cough, Cold and Flu Drugs, Dermatologics, Gastrointestinal drugs, Vitamins and Minerals, Weight Loss/Diet Drugs, Sleep Aids, Ophthalmics, Smoking Cession Aids and Other Products. Cough and Cold preparations is the largest segment in the United States Over the Counter Drugs Market accounting for a share of approximately 21% followed by Analgesics with a percentage share of 14%. By distribution channels market is segmented into pharmacies, supermarkets/Hypermarkets, convenience stores and others. Pharmacies / drugstores accounted for the largest market share of the distribution channel segment accounting for a share of 58% followed by supermarkets with a share of 35%.

Some of the major companies dominating the market are GlaxoSmithKline, Johnson and Johnson, Novartis, Bayer, Pfizer, Boehringer Ingelheim, Sanofi, Takeda and PGT Healthcare

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Formulation Type                              

                                5.1.1 Tablets      

                                5.1.2 Liquids      

                                5.1.3 Ointments               

                                5.1.4 Sprays       

                5.2 By Applications                         

                                5.1.1 Analgesics

                                5.1.2 Cough, Cold and Flu Products         

                                5.1.3 Antiseptics              

                                5.1.4 Dermatologics       

                                5.1.5 Gastrointestinal Drugs       

                                5.1.6 Vitamins and Minerals       

                                5.1.7 Anti-Allergy Drugs

                                5.1.8 Weight Loss / Diet Drugs   

                                 5.1.9 Sleep Aids              

                                5.1.10 Ophthalmics         

                                5.1.11 Smoking Cession Aids      

                                5.1.12 Other Products   

                5.3 By Distribution Channels                       

                                5.2.1 Pharmacies             

                                5.2.2 Supermarkets/Hypermarkets         

                                5.2.3 Convenience Stores            

                                5.2.4 Others      

6. Strategic Analysis                                       

                6.1 PESTLE analysis                         

                                6.1.1 Political     

                                6.1.2 Economic 

                                6.1.3 Social         

                                6.1.4 Technological         

                                6.1.5 Legal          

                                6.1.6 Environmental       

                6.2 Porter’s Five analysis                              

                                6.2.1 Bargaining Power of Suppliers        

                                6.2.2 Bargaining Power of Consumers    

                                6.2.3 Threat of New Entrants     

                                6.2.4 Threat of Substitute Products and Services              

                                6.2.5 Competitive Rivalry within the Industry     

7. Market Leaders' Analysis                                        

                7.1 GlaxoSmithKline                       

                                7.1.1 Overview 

                                7.1.2 Product Analysis   

                                7.1.3 Strategic Evaluation and Operations            

                                7.1.4 Financial analysis  

                                7.1.5 Legal issues             

                                7.1.6 Recent Developments       

                                7.1.7 SWOT analysis       

                                7.1.8 Analyst View          

                7.2 Johnson and Johnson                            

                7.3 Novartis                       

                7.4 Bayer                            

                7.5 Pfizer                            

                7.6 Boehringer Ingelheim                            

                7.7 Sanofi                           

                7.8 Takeda                         

                7.9 PGT Healthcare                         

8. Competitive Landscape                                           

                8.1 Market share analysis                            

                8.2 Merger and Acquisition Analysis                       

                8.3 Agreements, collaborations and Joint Ventures                         

                8.4 New Product Launches                         

9. Expert Opinions                                          

                9.1 Market Outlook                        

                9.2 Investment Opportunities                   

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
North America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Middle East And Africa High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application...
Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Europe High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glau...
Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology...
High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, H...
North America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Middle East And Africa Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pestici...
Latin America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Europe Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...
Asia Pacific Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screeni...
Global Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.